Dapagliflozin Treatment in Type 2 Diabetes
NCT04620590
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Impaired Renal Function
Interventions
DRUG:
Dapagliflozin 10 MG [Farxiga]
Sponsor
Emerald Clinical Inc.
Collaborators
[object Object]
[object Object]